Navigation Links
Sheller, P.C. Law Firm Instrumental in Pfizer's $2.3 Billion Settlement Today in Largest Pharmaceutical Whistleblower Case in History
Date:9/2/2009

he's been able to return millions of ill-gotten gains to taxpayers," said Brian J. McCormick, Esq., of Sheller, P.C. who also represents the relator/whistleblower.

Among the off-label promotion by Pfizer for Zyvox, according to the complaint:

  • Promoting Zyvox for the treatment of catheter related skin infections and concomitant bloodstream infections associated with catheter related skin infections. Zyvox's FDA approved labeling does not support this claim and it constitutes an off-label promotion.
  • Promoting Zyvox for the treatment of surgical site infections or as a prophylaxis for the prevention of surgical site infections. Zyvox's FDA approved labeling does not support this claim and it constitutes an off-label promotion.
  • Promoting Zyvox as clinically superior to vancomycin. Zyvox's FDA approved labeling does not support this claim and it constitutes an off-label promotion.
  • Promoting Zyvox as effective for all infections caused by MRSA including community acquired MRSA. Zyvox's FDA approved labeling does not support this claim and it constitutes an off-label promotion.
  • Promoting Zyvox as an appropriate choice "anywhere on the treatment continuum" regardless of the infection. Zyvox's FDA approved labeling does not support this claim and it constitutes an off-label promotion.
  • Promoting Zyvox as appropriate empiric therapy for all bacterial infections even though it has no effect on gram negative infections and only partial effect on polymicrobial infections. The promotion of Zyvox as appropriate empiric therapy for all infections constitutes an off-label promotion.

The government also discovered that Pfizer offered and paid illegal compensation to health care professionals to induce them to promote and prescribe Zyvox in violation of federal kickback laws.

"What Pfizer did with Z
'/>"/>

SOURCE Sheller, P.C. Law Firm
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Thelen Instrumental in Closing $1 Billion Outsourcing Deal for Client Harvard Pilgrim Health Care
2. Hospital infections cost $1 billion in lost bed days
3. MarketsandMarkets: Global Emerging Lighting Technologies Market Worth US$112.2 Billion by 2014
4. Increasing Health Center Capacity by 20 Million Patients Could Save More Than $200 Billion Over the Next Decade
5. U.S. Compression Therapy Market to Reach $1.16 Billion in 2015, Finds Frost & Sullivan
6. MarketsandMarkets: Global Biomarker Market Worth US$ 20.5 Billion by 2014
7. Cardinal Health Announces $1.2 Billion Debt Tender Offer
8. MarketsandMarkets: Top Ten Medical Device Technologies Market Worth $454.3 Billion by 2014
9. New Study of House Health Reform Bill: California Faces Over $3.7 Billion in Medicare-Funded Nursing Home Cuts Over Ten Years
10. New Study of House Health Reform Bill: Minnesota Faces Over $654 Billion in Medicare-Funded Nursing Home Cuts Over Ten Years
11. New Study of House Health Care Reform Bill: Texas Faces Over $2.7 Billion in Medicare-Funded Nursing Home Cuts Over Ten Years

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... Three new interactive anatomy education apps fr...expand health sciences learning opportunities for ...urham, NC (Vocus) November 27, 2009 -- Modality, ... a division of Wolters Kluwer Health, today announ...n apps on the App Store. Clemente’s Anatomy,...
(Date:11/26/2009)...ng drug tetrathiomolybdate (TM) has been shown in ... disease, a disease caused by an overload of coppe...own. Very little, however, is known about how the ... led by Northwestern University researchers now ha...al structure of TM bound to copper-loaded metalloc...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again Center, a ... is one of a growing number of physicians who are ...es to connect with individuals who are interested ...obesity. Dr. Kim is utilizing Facebook to share be...actice with the community. , ...
(Date:11/25/2009)...., Nov. 25 When most pe...tist. But a chiropractor can also give patients t...dibular Joint, which is where your jaw (mandible) ... ,, The most common symptoms associated with T...popping of the jaw. But many other symptoms can b...
(Date:11/25/2009)...v. 25 /PRNewswire/ - Sentinelle Medical Inc., a le...d visualization software launches a suite of new l... medical imaging software platform at this year,s ...l meeting in Chicago, Nov. 30 - Dec. 5, 2009 (Boot...que high quality images generated by Sentinelle,s ...
Breaking Medicine News(10 mins):Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 4
...8 The organizers of a massive community-wide even... the underinsured and un-insured originally planne...Remote Area Medical), ramohio.org, the group behin... due to the spreading threat of swine flu infectio...
...ril 28 Healthcare Realty Trust Incorporated (NYSE...ay 11, 2009, after the market closes, it will repo...n May 12, 2009, at 9:00 a.m. Central Time, Healthc... Simultaneously with the conference call, a webc...
...tes, their families and friends participate in 200...early 1,000 Anthem Blue Cross associates and their... in the parent company,s national Community Servic...s, Antioch, Calif. , El Proyecto Del Barrio ...
...ase in Revenues , , DALLAS, April 28 Claimsn...provider of Internet-based business-to-business so...d its results for the first quarter of fiscal 2009...ported for the first quarter of 2008. , , Expense...
...topoisomerase II alpha ( TOP2A ) gene were associa...ycline-based therapy compared with non-anthracycli...il 28 online issue of the Journal of the National...eral studies have shown that women whose tumors ha...
... Oregon Health & Science University Knight Cancer ...rt image-guidance system called Calypso (Calypso M...ing highly precise radiation therapy to head and n...and it is our hope to apply this system to multipl...
Other Medicine News:Health News:RAM Ohio Free Medical Clinic Cancelled Due to Swine Flu Outbreak 2Health News:Healthcare Realty Trust Announces First Quarter Earnings Release Date and Conference Call 2Health News:Anthem Blue Cross Associates Volunteer to Help California Organizations During Second Annual Community Service Day 2Health News:Anthem Blue Cross Associates Volunteer to Help California Organizations During Second Annual Community Service Day 3Health News:Claimsnet.com Reports First Quarter 2009 Results 2Health News:Claimsnet.com Reports First Quarter 2009 Results 3Health News:Gene alterations associated with response to anthracycline therapy for breast cancer 2Health News:OHSU Knight Cancer Institute to study new radiation technology for head, neck cancer 2
(Date:11/25/2009)... The FDA granted traditional approv...-nucleoside reverse transcriptase inhibitor (NNRTI...ted for use in treatment-experienced adults who ar...s resistant to an NNRTI and other antiretroviral (... 48-week data from two Phase 3 studies known as DU...
(Date:11/25/2009)... 25 Regado Biosciences, a privatel...mbotic aptamers with active control agents, announ... be presenting at the Piper Jaffray 21st Annual He...in New York City. Dr. Mazzo,s presentation will b... will include an overview of the Company,s pipelin...
(Date:11/25/2009)... Abaxis, Inc. (Nasdaq: ...oint-of-care blood analysis systems, announced tod...ve officer, will present at the 21st Annual Piper ...ber 2, 2009 at 2:00 p.m. ET. The conference will b...ty. ,, About Abaxis ,, Abaxis develops, m...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2New synthetic molecules trigger immune response to HIV and prostate cancer 10644 1New synthetic molecules trigger immune response to HIV and prostate cancer 10644 2Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 1Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 2Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 3Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 4Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 5Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 6Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 7Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 14742 1Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 14742 2
...g, SOMERSET, N.J., April 14 Alfacell Corporation...ee with the University of,Pennsylvania has reporte...,promising radiation sensitizer for lung cancer tr...o and in vitro data in a poster at the 2008 Americ...eting being held April 12 -,16 in San Diego., In ...
...il 14, at 8:30 a.m. E.T. at ...ril 14 Isis,Pharmaceuticals, Inc. (Nasdaq: ISIS ...ase 2 open-label extension (OLE) study of mipomers...(FH). In FH patients exposed to,mipomersen for as ...continues to be encouraging. Reductions in LDL-cho...
Other Medicine Technology:Alfacell's ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment 2Alfacell's ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment 3Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 2Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 3Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 4Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 5Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 6
...f-the-art quality in an instrument of extremely lo...ty. Low profile cutting tips allow access to patho...re available in just about every cutting tip style...t arthroscopic procedures.,Arthrex offers a lifet...
...f-the-art quality in an instrument of extremely lo...ty. Low profile cutting tips allow access to patho...re available in just about every cutting tip style...t arthroscopic procedures.,Arthrex offers a lifet...
...f-the-art quality in an instrument of extremely lo...ty. Low profile cutting tips allow access to patho...re available in just about every cutting tip style...t arthroscopic procedures.,Arthrex offers a lifet...
...f-the-art quality in an instrument of extremely lo...ty. Low profile cutting tips allow access to patho...re available in just about every cutting tip style...t arthroscopic procedures.,Arthrex offers a lifet...
Medicine Products: